Sign In

Matthew Osman

2x AI founder and ex-hedge trader and barrister.

Matthew Osman is a serial entrepreneur and AI company founder based in Brooklyn, New York. He is currently the Co-Founder and CEO of Treat, a startup he established in October 2021.1 Treat is focused on using generative AI to enhance creative processes and personalize online shopping experiences for brands.2

Professional Background

Prior to founding Treat, Matthew had a diverse career spanning multiple industries:

  • AI and Biotech: He previously founded and sold a life science AI startup called Legit.ai, which was acquired by Clora in 2020.1
  • Finance: Matthew worked as part of the credit team at Pearl Diver Capital, an asset manager specializing in CLO investments.1
  • Law: He has a background as a barrister, holding a Postgraduate Diploma in Bar Professional Training from City University London.

Education and Achievements

Matthew's educational background includes:

  • Bachelor of Arts in Philosophy, Politics, and Economics from the University of Oxford
  • Studies at Eton College and the CFA Institute

He was awarded the Lord Denning Scholarship by Lincoln's Inn, recognizing his academic achievements.1

Current Ventures

In addition to his role at Treat, Matthew is:

  • A Longevity Biotech Fellow at the Longevity Biotech Fellowship1
  • Involved in angel investing, with a particular interest in marketplaces

Recent Developments

In April 2023, Matthew announced that Treat had raised $8.5 million in seed funding from Greylock Partners, led by Mike Duboe.2 This funding is aimed at furthering Treat's mission to help brands leverage generative AI for creative strategies and personalized shopping experiences.

Highlights

Apr 4 · linkedin

I'm thrilled to announce that Treat has raised $8.5 million from Greylock in a seed round led by Mike Duboe! 👉 https://bit.ly/3zsTby6

🚀 This exciting milestone marks the beginning of a new chapter for Treat as we embark on our mission to help brands use generative AI to turbocharge creative and individually personalize every online shopping experience.

💪 Our entire team is focused on empowering DTC marketers and brands to unlock the full power of their data to fuel creative strategies, effortlessly generate on-brand high quality visuals, and achieve true personalization at scale.

📣 In addition to Greylock, I'd like to highlight our entire group of amazing investors: Timothy Young Nik Sharma TJ Mahony Cédric Kovacs-Johnson Ed Roman Brian Long Hunter Walk Jeff Truong Ed Hallen Taylor 👨🏻‍💻 Sicard Andrew Adams Ajay Mehta Adam Bridegan Gabby Contro Ben Jabbawy Isabelle Phelps Nick Rellas Adam Turner Ian Rountree William Smith Dallas Thompson

🗣 Lastly, a shout out to our brilliant group of advisors: Chance Riley Matt Thelen Nicholas Karrat Chris Mikulin Alex Becker Gareth Everard Beau Avril

Stay tuned for more exciting updates as we continue to develop and expand the capabilities of Treat!

If you're in the eComm/DTC space and want to connect on all things creative and AI-- lets talk 👋

Related Questions

What inspired Matthew Osman to transition from hedge trading to AI startups?
How did Matthew Osman's background in law influence his entrepreneurial ventures?
What are the key features of Treat's generative AI platform?
How did the acquisition of Legit.ai by Clora impact Matthew Osman's career?
What are some of the notable projects Matthew Osman has worked on at Treat?
Matthew Osman
Matthew Osman, photo 1
Matthew Osman, photo 2
Add to my network

Experience

Founder & CEO at Treat, Longevity Biotech Fellow at Longevity Biotech Fellowship
Vice President Strategy at Clora, CEO & Co-Founder at Legit, Credit Team at Pearl Diver Capital

Location

Brooklyn, New York, United States